Several molecular markers are crucial in understanding and managing cancer. Some of the most studied markers include:
BRCA1 and BRCA2: Genes associated with breast and ovarian cancer. KRAS: Mutations in this gene are common in several cancers, including colorectal cancer. HER2: Overexpression is seen in some breast cancers and can be targeted by specific therapies. TP53: Mutations in this tumor suppressor gene are found in many types of cancer.
These markers are pivotal for diagnosis, treatment planning, and monitoring disease progression.
